6 hours BIO Gears Up for Q3 Earnings: Here’s What You Need to KnowZacks
Within Bio-Rad’s Life Science business, the ongoing weakness in the biotech and biopharma end markets might have severely affected sales.
XWithin Bio-Rad’s Life Science business, the ongoing weakness in the biotech and biopharma end markets might have severely affected sales.
X